Azuma et al., “B70 Antigen is a Second Ligand for CTLA-4 and CD28” Nature 366, 76-79 (1993). |
Blazar et al., “In Vivo Blockade of CD28/CTLA4: B7/BB1 Interaction With CTLA4-Ig Reduces Lethal Murine Graft-Versus-Host Disease Across the Major Histocompatibility Complex Barrier in Mice” Blood 83(12) 3815-3825 (1994). |
Boussiotis et al., “Activated Human B Lymphocytes Express Three CTLA-4 Counter receptors that Costimulate T-Cell Activation” Proc. Natl. Acad. Sci. USA 90, 11059-1163 (1993). |
Caine, “Immunosuppression for Organ Grafting” Trans. Proceedings 24(4) 1260-1262 (1992). |
Carlson et al., “Effects of Orally Administered Rapamycin in Animal Models of Arthritis and Other Autoimmune Diseases” Annals NY Acad. of Sci. 86-113. |
Carter, “Adeno-Associated Virus Vectors” Curr. Biol. 3, 533-539 (1992). |
Chen et al., “Multitarget-Ribozyme Directed to Cleave at up to Nine Highly Conserved HIV-1 Env RNA Regions Inhibits HIV-1 Replication-Potential Effectiveness Against Most Presently Sequenced HIV-1 Isolates” Nucl. Acid Res. 20(17) 4581-4589 (1992). |
Chowrira et al., “Extensive Phosphorothioate Substitution Yields Highly Active and Nuclease-Resistant Hairpin Ribozymes” Nucl. Acids Res. 20(11) 2835-2840 (1992). |
Chowrira et al., “In Vitro and In Vivo Comparison of Hammerhead, Hairpin and Hepatitis Delta Virus Self-Processing Ribozyme Cassettes” J. of Biol. Chem. 269(41) 25856-25864 (1994). |
Clark et al., “How B and T Cells Talk to Each other” Nature 367, 425-428 (1994). |
Cohen et al., “New Protein Steals the Show as ‘Costimulator’ T Cells” Science p. 262 (1993). |
Collins et al., “Reaction Conditions and Kinetics of Self-Cleavage of a Cleavage of a Ribozyme Derived for Neurospora VS RNA”Biochem 32, 2795-2799 (1992). |
Drouplic et al., “Functional Characterization of a U5 Ribozyme: Intracellular Suppression of Human Immunodeficiency Virus Type 1 Expression” J. of Virology 66(3) 1432-1441(1992). |
Duval-Valentin et al., “Specific Inhibition of Transcription by Triple Helix-Forming Oligonucleotide” Proc. Natl. Acad. Sci. USA 89, 504-508 (1992). |
Egholm et al., “PNA Hybridizes to Complementary Oligonucleotides Obeying the Watson-Crick Hydrogen-Bonding Rules” Nature 365, 566-568 (1993). |
Elroy-Stein et al., “Cytoplasmic Expression System Based on Constitutive Synthesis of Bacteriophage T7 RNA Polymerase in Mammalian Cells” Proc. Natl. Acad. Sci. USA 87, 6743-6747 (1990). |
Finck et al., “Treatment of Murine Lupus with CTLA4lg” Science 265, 1225-1227 (1994). |
Fodor et al., “Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of Xenogeneic Hyperacute Organ Rejection”Proc. Natl. Acad. Sci. USA 91, 11153-11157 (1994). |
Freeman et al., “Uncovering of Functional Alternative CTLA-4 Counter-Receptor in B7-Deficient Mice” Science 262, 907-909 (1993). |
Fuleihan et al., “Cyclosporin A Inhibits CD40 Ligand Expression in T Lymphocytes” J. Clin. Invest. 93, 1315-1320 (1994). |
Gao et al., “Cytoplasmic Expression of a Reporter Gene by Co-Delivery of T7 RNA Polymerase and T7 Promoter Sequence With Cationic Liposomes” Nucl. Acid Res. 21(12) 2867-2872 (1993). |
Guerrier-Takada et al., “The RNA Moiety Ribonuclease P is the Catalytic Subunit of the Enzyme” Cell 35, 849-857 (1983). |
Hampel et al., “RNA Catalytic Properties of the Minumum (=)s TRSV Sequence” Am. Chem. Soc. 28, 4929-4933 (1989). |
Hampel et al., “‘Hairpin’ Catalytic RNA Model: Evidence for Helices and Sequence Requirement for Substrate RNA” Nucl. Acid. Res. 18(2) 299-304 (1989). |
Harding et al., “CD28-Mediated Signalling Co-Stimulates Murine T Cells and Prevents Induction of Anergy in T-Cell Clones” Nature 356, 607-609 (1992). |
Haseloff et al., “Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities” Nature 334, 585-591 (1988). |
Hathcock et al., “Comparitive Analysis of B7-1 and B7-2 Costimulatory Ligands: Expression and Function” J. of Exper. Medicine 180, 631-640 (1994). |
Hathcock et al., “Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation” Science 262, 905-907 (1993). |
Hertel et al., “Numbering System for the Hammerhead” Nucl. Acids Res. 20(12) 252 (1992). |
Jaeger et al., “Improved Predictions of Secondary Structures for RNA” Proc. Natl. Acad Sci. USA 86, 7706-7710 (1989). |
Janeway et al., “Signals and Signs for Lymphocyte Responses” Cell 76, 275-285 (1994). |
Jeffries et al., “A Catalytic 13-mer Ribozyme,” Nucleic Acids Research 17:1371-1377 (1989). |
Jenkins et al., “Molecular Events in the Induction of Nonresponsive State in Interleukin 2-Producing Helper T-Lymphocyte Clones” Proc. Natl Acad. Sci USA 84, 5409-5413 (1987). |
Kashani-Sabet et al., “Reversal of the Malignant Phenotype by an Anti-ras Ribozyme” Antisense Res. and Dev. 2, 3-15 (1992). |
Kemeny et al., “Can Persistent IgE Responses be Suppressed?” Clin Exp. Immunol. 82, 423-426 (1990). |
Kim et al., “Three Dimensional Model of the Active Site of the Self-Splicing rRNA Precursor of Tetrahymena” Proc. Natl. Acad. Sci 84, 8788-8792 (1987). |
Koulova et al., “The CD28 Ligand B7/BB1 Provides Costimulatory Signal for Alloactivation of CD4+ T Cells” J. Exp. Med. 173, 759-762 (1991). |
Kuchroo et al., “B7-1 and B7-2 Costimulatory Molecules Activate Differentially the Th1/Th2 Developmental Pathways: Application to Autoimmune Disease Therapy” Cell 80, 707-718(1995). |
Lenschow et al., “Expression and Functional Significance of an additional Ligand for CTLA-4” Proc. Natl. Acad. Sci 90, 11054-11058 (1993). |
Lenschow et al., “Long-Term Survival of Xenogenic Pacreatic Islet Grafts Induced by CTLA4lg” Science 257, 789-792 (1992). |
L'Hullier et al., “Cytoplasmic Delivery of Ribozymes Lead to Efficient Reduction in α-Lactalbumin mRNA Levels in C127I Mouse Cells” EMBO J. 11(12) 4411-4418 (1992). |
Lieber et al., “Stable High-Level Gene Expression in Mammalian Cell By T7 Phage RNA Polymerase” Methods in Enzymol. 217, 47-66 (1993). |
Linsley et al., “Binding of the B Cell Activation Antigen B7 to CD28 Costimulates T Cell Proliferation and Interleukin 2 mRNA Accumulation” J. Exp. Med. 173, 721-730 (1991). |
Linsley et al., “Immunosuppression In Vivo by a Soluble Form of The CTLA-4 T Cell Activation Molecule” Science 257, 792-795 (1992). |
Lisziewicz et al., “Inhibition of Human Immunodeficiency Virus Type 1 Replication By Regulated Expression of a Polymeric Tat Activation Response RNA Decoy as a Strategy for Gene Therapy in AIDS” Proc. Natl. Acad. Sci USA 90, 8000-8004 (1993). |
Marshall et al., “The Molecular Basis for T Cell Help in Humoral Immunity: CD40 and Its Ligand, gp39” J of Clin. Immunol. 13(3) 165-174 (1993). |
Milligan et al., “ Synthesis of Small RNAs Using T7 RNA Polymerase” Methods in Enzymol. 180, 51-62 (1989). |
Nowak, “ Xenotransplants Set to Resume” Science 266, 1148-1151 (1994). |
Ohkawa et al., “Activities of HIV-RNA Targeted Ribozymes Transcribed Form a ‘Shot-Gun’ Type Ribozyme-Trimming Plasmid” Oxford Univ. Press 15-16 (1992). |
Ojwang et al., “Inhibition of Human Immunodeficiency Virus Type 1 Expression by a Hairpin Ribozyme” Proc. Natl Acad. Sci. 89, 10802-10806 (1992). |
Perreault et al., “Mixed Deoxyribo- and Ribo-Oligonucleotide with Catalytic Activity” Nature 344, 565-567 (1990). |
Perrotta et al., “Cleavage of Oligoribonucleotides by Ribozyme Derived From The Hepatitis δ Virus RNA Sequence” Am. Chem. Soc. 31, 16-21 (1992). |
Pieken et al., “Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes” Science 253, 314-317 (1991). |
Pretolani et al., “Cytokines-Eosinophil Interactions in Experimental Allergy” Annals NY Acad of Sci. 725, 247-258 (1994). |
Rossi et al., “RNA Enzymes (Ribozymes) as Antiviral Therapeutic Agents” Tibtech 8, 179-183 (1990). |
Sarver et al., “Ribozymes as a Potential Anti-HIV-1 Therapeutic Agents” Science 247, 1222-1225 (1990). |
Saville et al., “A Site-Specific Self-Cleavage Reaction Performed by a Novel RNA in Neurospora Mitochondria” Cell 61,685-696 (1990). |
Saville et al., “RNA-Mediated Litigation of Self-Cleavage Products of a Neurospora Mitochondrial Plasmid Transcript” Proc. Natl. Acad. Sci. USA 88, 8826-8830 (1991). |
Scanlon et al., “Ribozyme-Mediated Cleavage of C-fos mRNA Reduces Gene Expression of DNA Synthesis Enzymes and Metallothionein” Proc. Natl. Acad. 88, 10591-10595 (1991). |
Scaringe et al., “Chemical Synthesis of Biologically Active Oligoribonucleotides Using β-Cyano ethyl Protected Ribonucleoside Phospharamidites” Nucl. Acid Res. 18(18) 5433-5441 (1990). |
Stein et al., “Antisense Oligonucleotide as Therapeutic Agents—Is the Bullet Really Magic?” Science 261, 1004-1012 (1993). |
Taira et al., “Construction of a Novel RNA-Transcription-Trimming Plasmid Which Can Be Used Both In Vitro In Place of Run-Off and (G)-Free Transcriptions and In Vivo as Multi-Sequences Transcription Vectors” Nucl. Acids Res. 19(19) 5125-5130 (1991). |
Torrence et al., “Targeting RNA for Degradation with a (2′-5′) Oligoadenylateantisense Chimera” Proc. Natl. Acad. Sci USA 90, 1300-1304 (1993). |
Turka et al., “T-Cell Activation by the CD28 Ligand B7 is Required for Cardiac Allograft Rejection In Vivo” Proc. Natl. Acad. Sci. 89, 11102-11105 (1992). |
Uhlenbeck, “A Small Catalytic Oligoribonucleotide” Nature 328, 596-900 (1987). |
Usman et al., “ Exploiting the Chemical Synthesis of RNA” TIBS 17, 334-339 (1992). |
Usman et al., “Automated Chemical Synthesis of Long Oligoribonucleotides Using 2′-O-Silylated Ribonucleoside 3′-O-Phosphoramidites on a Controlled-Pore Glass Support: Synthesis of a 43-Nucleotide Sequence Similar to the 3′-Half Molecule of an Escherichia Coli Formylmethionine tRNA” Am. Chem. Soc. 109(25) 7845-7854 (1987). |
Van Gool et al., “Synergy Between Cyclosporin A and a Monoclonal Antibody to B7 in Blocking Alloantigen-Induced T-Cell Activation” Blood 83(1) 176-183 (1994). |
Van Laar et al., “Towards T Cell Vaccination in Rheumatoid Arthritis” Chem Immunol. 58, 206-235 (1994). |
Ventura et al., “Activation of HIV-Specific Ribozyme Activity by Self-Cleavage” Nucl. Acid Res. 21(14) 3249-3255 (1993). |
Weerasinghe et al., “Resistance to Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Human CD4+ Lymphocyte-Derived Cell Lines Conferred by Using Retroviral Vectors Expressing an HIV-1 RNA-Specific Ribozyme” J. Virol. 65(10) 5531-5534 (1991). |
Wekerle et al., “Animal Models” Annals of Neurol. 36, s47-s53 (1994). |
Yu et al., “A Hairpin Ribozyme Inhibits Expression of Diverse Strains of Human Immunodeficiency Virus Type 1” Proc. Natl. Acad. Sci. USA 90, 6340-6344 (1993). |
Zabner et al., “Adenovirus-Mediated Gene Transfer Transiently Corrects the Chloride Transport Defect in Nasal Epithelia with Cystic Fibrosis” Cell 75, 207-216 (1993). |
Zhou et al., “Synthesis of Functional mRNA in Mammalian Cells By Bacteriophage T3 RNA Polymerase” Mol. Cell. Biol. 10(9) 4529-4537 (1990). |
Branch TIBS 23:45-50, Feb. 1998. |
Flanagan et al. Nature Biotechnology 17:48-52, Jan. 1999. |